Mandate

Vinge advises Active Biotech in relation to directed new share issue

April 04, 2013

In March this year, Active Biotech AB (publ) conducted a directed new share issue to Investor AB (publ) pursuant to which Active Biotech procured SEK 270 million.

Vinge’s team consisted of partner Erik Sjöman and associate Christian Lindhé.

Related

Vinge has advised private equity firm Stirling Square Capital Partners

Vinge has advised private equity firm Stirling Square Capital Partners in connection with its acquisition of a majority stake in Infobric, a leading provider of software solutions for the construction industry, from Summa Equity.
September 22, 2023

Vinge advises Stendörren in connection with issuance of green notes and tender offer

Vinge has advised Stendörren Fastigheter AB in connection with its issuance of senior unsecured green notes in an amount of SEK 500 million (within a framework of SEK 600 million) and its parallel tender offer in respect of its previously issued notes due 2024.
September 21, 2023

Vinge has advised Elektroskandia in connection with its majority investment in Aprilice

Vinge has advised Elektroskandia (a Sonepar company) in connection with its acquisition of 70% of the shares in Aprilice, one of the leading solar energy platforms in Northern Europe.
September 20, 2023